Life Sciences on the Rise: 2021 North American Report

PUBLIC & PRIVATE FUNDING (2020-2021)

COMPANY

DEAL TYPE

COMPLETED

TYPE

$ RAISED (MM)

Passage Bio

IPO

Feb 2020 Mar 2021 Sep 2020 Aug 2020 Dec 2020 Apr 2020 Mar 2020 May 2020 Jul 2020

Public

$216.0 $160.0 $158.2 $147.6 $112.0 $88.0 $77.0 $75.0

Century Therapeutics Prelude Therapeutics Harmony Biosciences

Later Stage

VC

IPO IPO

Public Public

Imvax

Later Stage Early Stage Early Stage Early Stage

VC VC VC VC

Aro Biotherapeutics SwanBio Therapeutics Castle Creek Biosciences Ayala Pharmaceuticals Carisma Therapeutics

IPO

Public

$59.1

Early Stage

Jul 2020

VC

$59.0

RENT VS. VACANCY COMPARISON

NNN Rents

Vacancy Rate

$10.00 $15.00 $20.00 $25.00 $30.00 $35.00 $40.00 $45.00

6.0%

Vacancy Rate

3.0%

NNN Rent $/sf

$0.00 $5.00

0.0%

2015

2016

2017

2018

2019

2020

Source: CoStar, Cushman & Wakefield Research

REPRESENTATIVE INVESTMENT SALE TRANSACTIONS (2019-2021)

ADDRESS

TYPE

$ MM RBA SF $83.0 246,806 $79.0 142,000 $77.0 122,000

DATE

BUYER

4701 League Island Blvd

Lab Lab Lab

Aug 2020 Ensemble Investments

3701 Market St

Jun 2021 Mar 2021

GI Partners

125 S 31st St

Blackstone Group

REPRESENTATIVE LEASE TRANSACTIONS (2020)

COMPANY

ADDRESS

SIZE (SF) NEW/RENEWAL TYPE

QUARTER LANDLORD

Iovance Biotherapeutics

300 Rouse Blvd

136,000 New

Lab/cGMP Q2

Gattuso Development Partners

Amicus Therapeutics

3675 Market St

76,069 New

Lab, Office Q1

Wexford Science & Technology

Spark Therapeutics

3000 Market S

55,000 New

Lab

Q2

Brandywine Realty Trust

Catalent Pharma Solutions Jefferson Bioprocessing Center

333 Phoenixville Pike 84,000 New

Lab

Q4

Workspace Property Trust

727 Norristown Rd, Ambler

41,000 New

Lab

Q2

MRA Group

Century Therapeutics

One uCity

32,000 New

Lab

Q2

Wexford Science & Technology

Exponent Inc

One uCity

32,000 New

Lab, Office Q3

Wexford Science & Technology

Integral Molecular

One uCity

32,000 New

Lab, Office Q1

Wexford Science & Technology

Biomeme

401 N Broad

41,000 New

Flex, Lab Q1 2021

Netrality

411 Swedeland Rd, King of Prussia

Penn Gene Therapy

170,000 New

Lab, cGMP Q2 2021

MLP Ventures

/ 35

Contributor: David Spragg, david.spragg@cushwake.com